LC-MS for RNA Therapeutics to Ensure Product Quality and Process Consistency
41:21
LC-MS for RNA Therapeutics to Ensure Product Quality and Process Consistency
Share
Related Videos
In Biopharma & Pharma
-
Play video Streamlined mAb Subunit LC-MS Workflow for Multiple Attribute Monitoring of Biosimilar mAb Candidates During Bioprocessing and Development
Streamlined mAb Subunit LC-MS Workflow for Multiple Attribute Monitoring of Biosimilar mAb Candidates During Bioprocessing and Development
Clone selection, early in the development lifecycle, has an outsize impact on the ability to match the quality target product profile (QTPP) for a given product.
38:53
-
Play video Robust Multi-Level LC-MS Workflows for Biosimilar Comparability Assessment
Robust Multi-Level LC-MS Workflows for Biosimilar Comparability Assessment
Watch this presentation to learn about the uses of the Xevo G3 QTof mass spectrometer in a case study of biosimilar mAb characterization at intact, subunit, and peptide level.
48:24
-
Play video Similis Bio Enhances Biosimilar Development with Waters Solutions
Similis Bio Enhances Biosimilar Development with Waters Solutions
Learn how Similis Bio implemented a streamlined mAb subunit LC-MS workflow for Multiple Attribute Monitoring of biosimilar mAb candidates during bioprocessing and development.
38:53
-
Play video Chromatographic Techniques for the Characterization of CQAs in Biosimilars
Chromatographic Techniques for the Characterization of CQAs in Biosimilars
Critical to the development of a biosimilar is understanding the originator and how its CQAs compare against the biosimilar. Learn about solutions that provide high quality peptide mapping, glycan and charge variant data.
1:03:24
-
Play video Elevating Product Quality - BioAccord in Action Video
Elevating Product Quality - BioAccord in Action Video
Released N-linked glycan analysis is the gold standard for N-glycan profiling of therapeutic monoclonal antibodies (mAbs) as they play an important role in safety and efficacy.
25:51
-
Play video Automated LC-MS Workflow for CQA Assessment of Protein Therapeutics with Speed and Simplicity for Process Development
Automated LC-MS Workflow for CQA Assessment of Protein Therapeutics with Speed and Simplicity for Process Development
Here we demonstrate how sample prep has been greatly simplified and automated to enable rapid LC-MS (intact and subunit) analysis at higher throughput, with less human intervention, all while providing high quality to support process development.
1:01:40
